BKHAR
Black Hawk Acquisition Corp
Nasdaq Biological Products, (No Diagnostic Substances)
Emerging growth company

Key Financials

Net Income
$1.3M
↓ 30.6%
Operating Income
$-915510
↓ 58.9%
Total Liabilities
$3.9M
↑ 56.8%
Total Assets
$23.9M
↓ 66.9%
Cash & Equivalents
$0.00
NaN%
Shareholders' Equity
$-3846443.00
↓ 77.1%
Operating Cash Flow
$-650321.00
↓ 17.5%

Recent SEC Filings

Form Type Filed Date Link
425 9/25/2026 View on SEC
8-K 9/24/2026 View on SEC
8-K 9/22/2026 View on SEC
424B4 9/22/2026 View on SEC
EFFECT 9/17/2026 View on SEC
S-4/A 9/4/2026 View on SEC
8-K 8/26/2026 View on SEC
8-K 8/25/2026 View on SEC
S-4/A 8/3/2026 View on SEC
8-K 7/22/2026 View on SEC

Company Information

Field Value
Ticker BKHAR
Company Name Black Hawk Acquisition Corp
CIK 2000775
Sector Biological Products, (No Diagnostic Substances)
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1130
Phone 203-520-7122